HLAG Protein (Tetramer) (PE,HLA-G)
-
- Target Alle HLAG Proteine anzeigen
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- Tetramer
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses HLAG Protein ist gelabelt mit PE,HLA-G.
- Verwendungszweck
- PE-Labeled Human HLA-G & B2M & Peptide (RIIPRHLQL) Tetramer Protein
- Sequenz
- Gly25-Thr305 (HLA-G), Ile21-Met119 (B2M) and RIIPRHLQL peptide
- Spezifität
- Uni-Prot: P17693-1 (HLA-G), P61769 (B2M), RIIPRHLQL
- Produktmerkmale
- Recombinant PE-Labeled Human HLA-G & B2M & Peptide (RIIPRHLQL) Tetramer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus. PE-Labeled Human HLA-G & B2M & Peptide (RIIPRHLQL) Tetramer is assembled by biotinylated monomer and PE-labeled streptavidin.It contains Gly25-Thr305 (HLA-G), Ile21-Met119 (B2M) and RIIPRHLQL peptide.
- Sterilität
- 0.22 μm filtered
- Endotoxin-Niveau
- Less than 1EU per μg by the LAL method.
- Top Product
- Discover our top product HLAG Protein
-
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Tetramer) protein (HLA-G)
HLAG Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Tetramer) protein (HLA-G)HLAG Spezies: Cynomolgus Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Tetramer) protein (Biotin,HLA-G)HLAG Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Monomer) protein (Biotin,HLA-G)HLAG Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Tetramer) protein (HLA-G)HLAG Spezies: Rhesusaffen Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Monomer) protein (HLA-G)HLAG Spezies: Rhesusaffen Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Monomer) protein (HLA-G)HLAG Spezies: Cynomolgus Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (Monomer) protein (HLA-G)HLAG Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (AA 1-338) protein (GST tag)HLAG Spezies: Human Wirt: Wheat germ Recombinant WB, ELISA, AA, AP
HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (AA 25-337), (partial) protein (GST tag)HLAG Spezies: Human Wirt: Escherichia coli (E. coli) Recombinant 90 % ELISA
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as 0.22μm filtered solution in PBS, 0.2 % BSA ( pH 7.4).
- Lagerung
- -80 °C
- Informationen zur Lagerung
- Valid for 6 months from date of receipt when stored at -80°C., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- Andere Bezeichnung
- HLA-G (HLAG Produkte)
- Hintergrund
- HLA-G is a molecule that was first known to confer protection to the fetus from destruction by the immune system of its mother, thus critically contributing to fetal-maternal tolerance. The first functional finding constituted the basis for HLA-G research and can be summarized as such: HLA-G, membrane-bound or soluble, strongly binds its inhibitory receptors on immune cells (NK, T, B, monocytes/dendritic cells), inhibits the functions of these effectors, and so induces immune inhibition.
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-
